Sudarshan Pharma Board Meeting for Q2 Results, Fundraising

Board Meeting Details

• Meeting Date: Thursday, 29th October, 2026
• Primary Agenda Items:
• Consider and approve Unaudited Standalone Financial Results for quarter and half year ended 30th September, 2026
• Consider and approve Unaudited Consolidated Financial Results for quarter and half year ended 30th September, 2026
• Consider and approve proposal for raising funds through various instruments including:
• Equity shares
• Convertible securities of any description
• Warrants
• Debt securities
• Fundraising methods under consideration:
• Private Placement
• Preferential Issue
• Qualified Institutions Placement
• Other methods or combinations thereof
• Approval of ancillary actions required for the fundraising
• Subject to obtaining necessary statutory/regulatory approvals

Trading Window Status

The Trading Window of the Company shall remain closed until the expiry of 48 hours after the declaration of the financial results for the quarter and half year ended 30th September, 2026.